Table 6 Sociodemographic factors, comorbid disorders, benzodiazepine use and misuse during the most recent treatment episode for anxiety disorders^{c, d}

All

65.4

51

34.6

27

94.9

75

5.1

4

Gender

Male

50.0

11

50.0

11

95.5

21

4.6

1

Female

71.4

40

28.6

16

94.7

54

5.3

3

p*

0.073

1.000^a

Agegroup

<25 years

73.3

11

26.7

4

100.0

15

0.0

0

25–29 years

69.7

23

30.3

10

97.1

33

2.9

1

≥30 years

56.7

17

43.3

13

90.0

27

10.0

3

p*

0.428

0.402^a

Basic

Less than high school

64.9

24

35.1

13

97.4

37

2.6

1

education

High school

71.1

27

29.0

11

94.7

36

5.3

2

p*

0.566

1.000^a

Current

Employed

75.0

30

25.0

10

100.0

40

0.0

0

employment

Student

57.1

8

42.9

6

92.9

13

7.1

1

Unemployed

55.6

5

44.4

4

100.0

9

0.0

0

Other

66.7

8

33.3

4

84.6

11

15.4

2

p*

0.485^a

0.061^a

Married or

No

66.7

18

33.3

9

96.3

26

3.7

1

cohabiting

Yes

68.8

33

31.3

15

95.9

47

4.1

2

p*

0.853

1.000^a

Comorbid

Yes

66.7

32

33.3

16

93.8

45

6.3

3

mood

No

63.3

19

36.7

11

96.8

30

3.2

1

disorder

p*

0.763

1.000^a

Comorbid

Yes

43.5

10

56.5

13

87.0

20

13.0

3

substance use

No

74.6

41

25.5

14

98.2

55

1.8

1

disorder

p*

0.009

0.072^a

Comorbid

Yes

31.6

6

68.4

13

80.0

16

20.0

4

personality

No

76.3

45

23.7

14

100.0

59

0.0

0

disorder

p*

0.0004

0.003 ^a

Comorbid other

Yes

50.0

8

50.0

8

81.3

13

18.8

3

disorder^b

No

69.4

43

30.7

19

98.4

62

1.6

1

p*

0.147

0.025 ^a

More than 1

Yes

73.3

11

26.7

4

87.5

14

12.5

2

anxiety

No

63.5

40

36.5

23

96.8

61

3.2

2

disorder

p*

0.472

0.181^a